dr. joseph on selecting frontline therapy in mrcc
Published 5 years ago • 57 plays • Length 2:18Download video MP4
Download video MP3
Similar videos
-
1:22
dr. joseph on factors influencing frontline therapy selection in mrcc
-
1:25
dr. sznol on patient selection for combination therapy in mrcc
-
9:50
choosing frontline therapy for metastatic kidney cancer
-
1:21
dr. joseph on the combination of atezolizumab and bevacizumab in mrcc
-
5:11
selecting immunotherapy versus vegf tki for mrcc
-
8:21
cancer metastasis in the bones - all symptoms
-
48:57
i have stage iv renal cell carcinoma and i'm surprisingly content with joel stern
-
18:50
c15:0 update #1 | human studies and ferroptosis
-
2:52
frontline therapy options for mrcc
-
12:15
challenges of selecting frontline therapy in cll
-
7:58
utilizing frontline bevacizumab in metastatic renal cell carcinoma
-
8:56
frontline treatment approaches in advanced rcc
-
42:06
the uromigos: frontline therapy in rcc
-
1:52
dr. thiel on overall survival data from the carmena trial in mrcc
-
8:48
evaluating frontline systemic therapy for metastatic rcc
-
1:10
dr. mcdermott on the promise of pembrolizumab in non-clear cell rcc
-
6:57
newly diagnosed metastatic rcc: frontline therapy
-
1:42
dr. mcdermott on immotion150 trial in rcc
-
2:16
dr. rini on axitinib for treatment of metastatic renal cell carcinoma
-
3:47
other clinical trials in renal cell carcinoma
-
1:10
dr. motzer on first-line treatment of metastatic rcc
-
7:34
frontline sunitinib compared to everolimus in metastatic renal cell carcinoma